Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial

Gardado en:
Detalles Bibliográficos
Main Authors: Sockel, Katja, Bornhaeuser, Martin, Mischak-Weissinger, Eva, Trenschel, Rudolf, Wermke, Martin, Unzicker, Christian, Kobbe, Guido, Finke, Jürgen, Germing, Ulrich, Mohr, Brigitte, Greiner, Jochen, Beelen, Dietrich, Thiede, Christian, Ehninger, Gerhard, Platzbecker, Uwe
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2012
Assuntos:
Online-Only Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3436225/
https://ncbi.nlm.nih.gov/pubmed/22952334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.067629
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares